No relationship of −627 interleukin-10 promoter polymorphism in Chinese patients with rheumatoid arthritis
Authors:
- 25 June 2004
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 25 (8) , 576-579
Abstract
The aim of this study was to examine whether −627 interleukin-10 (IL-10) promoter polymorphism is a marker of susceptibility to or severity of rheumatoid arthritis (RA) in Chinese patients in Taiwan. The study included 198 Chinese patients with RA. One hundred unrelated healthy individuals living in central Taiwan served as the control subjects. The relationship between IL-10 gene polymorphism and clinical manifestations of RA was evaluated. For the genotype, allelic frequency, and carriage rate of IL-10 polymorphism, there were no statistically significant differences found between patients and controls. Furthermore, we did not detect any association of IL-10 genotype with rheumatoid factor (RF), extra-articular involvement, or bone erosion in the RA patients. The lack of association of −627 IL-10 gene polymorphism with RA and the clinical findings in our study implies that the IL-10 gene polymorphism cannot serve as a candidate gene marker for screening RA patients.Keywords
This publication has 27 references indexed in Scilit:
- Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver diseaseGut, 2000
- IL-10 Gene Promoter Polymorphisms in Rheumatoid Arthritis: SHORT REPORTScandinavian Journal of Rheumatology, 1998
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Interleukin-10 regulation in normal subjects and patients with asthmaJournal of Allergy and Clinical Immunology, 1996
- Immunoregulatory role of interleukin 10 in rheumatoid arthritis.Journal of Experimental Medicine, 1994
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.Journal of Experimental Medicine, 1993
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.Journal of Experimental Medicine, 1991
- Polygenic susceptibility in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1991
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988